Outlook Therapeutics, Inc. Share Price
NASDAQ: OTLK | Micro CapOutlook Therapeutics, Inc. Stock Performance
Open $1.01 | Prev. Close $1.03 | Circuit Range N/A |
Day Range $1.00 - $1.18 | Year Range $0.16 - $3.33 | Volume 2,96,130 |
Average Traded $1.09 |
Outlook Therapeutics, Inc. Share Price Today
As of 11 August 2026, Outlook Therapeutics, Inc.'s share price is $1.15. The stock opened at $1.01, compared to its previous close of $1.03. During today's trading session, Outlook Therapeutics, Inc.'s share price traded between $1.00 and $1.18, with an average price of $1.09. Over the past 52 weeks, the stock has recorded a high of $3.33 and a low of $0.16. In terms of performance, Outlook Therapeutics, Inc.'s share price has risen by 171.87% over the last six months and is up 35.14% on a year-on-year basis.
Outlook Therapeutics, Inc. Share Price Chart
Outlook Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $40.02M | PE Ratio (TTM) -0.64 | Dividend Yield N/A |
EPS (TTM) $-1.79 | Revenue (TTM) $1.41M | Return On Equity (TTM) N/A |
Profit Margin N/A | Debt to Equity -1.42 | Quarterly Earnings Growth YoY N/A |
Outlook Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Outlook Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration agreements with Cencora. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is headquartered in Iselin, New Jersey.
Outlook Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $0.94 | $1.15 | +17.59% |
Jul 2026 | $1.49 | $0.98 | -38.88% |
Jun 2026 | $0.74 | $1.60 | +119.48% |
May 2026 | $0.26 | $0.73 | +188.14% |
Apr 2026 | $0.21 | $0.25 | +25.87% |
Mar 2026 | $0.43 | $0.20 | -52.48% |
Feb 2026 | $0.43 | $0.42 | -3.20% |
Jan 2026 | $0.64 | $0.44 | -72.34% |
Dec 2025 | $1.79 | $1.58 | -11.98% |
Nov 2025 | $1.27 | $1.79 | +41.34% |
Oct 2025 | $1.07 | $1.27 | +20.38% |
Sep 2025 | $0.90 | $1.05 | +23.97% |
OTLK Share Price FAQs
What is Outlook Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Outlook Therapeutics, Inc. stock?
What is OTLK's market capitalisation today?
What is the 5 year returns of OTLK?
What is the high & low stock price of OTLK today?
Can I buy OTLK shares in India?